Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
The C-type lectin-like receptor CD161, which has recently been described to promote T cell expansion, is expressed on a discrete subset of human CD4 T cells. The function of such cells, however, has remained elusive. We now demonstrate that CD161(+) CD4 T cells comprise a circulating and gut-resident T helper 17 (Th17) cell population. During Crohn's disease (CD), these CD161(+) cells display an activated Th17 phenotype, as indicated by increased expression of interleukin (IL)-17, IL-22, and IL-23 receptor. CD161(+) CD4 T cells from CD patients readily produce IL-17 and interferon gamma upon stimulation with IL-23, whereas, in healthy subjects, priming by additional inflammatory stimuli such as IL-1beta was required to enable IL-23-induced cytokine release. Circulating CD161(+) Th17 cells are imprinted for gut homing, as indicated by high levels of CC chemokine receptor 6 and integrin beta7 expression. Supporting their colitogenic phenotype, CD161(+) Th17 cells were found in increased numbers in the inflammatory infiltrate of CD lesions and induced expression of inflammatory mediators by intestinal cells. Our data identify CD161(+) CD4 T cells as a resting Th17 pool that can be activated by IL-23 and mediate destructive tissue inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3. IL-23 drives IL-17 and IFN-γ production by CD161+ Th17 cells during inflammation. CD161+ and CD161− CD45RA−CD25−CD4+ T memory cells were FACS purified from PBMCs from healthy and CD donors. (A) Expression levels of il1r1 were determined by qRT-PCR and normalized to ubiquitin; data are from five different donors. Connecting lines indicate data points referring to the same donor. (B–F) Cells from healthy (B–E) or CD (F) donors were cultured for 3 d with anti-CD2/anti-CD3/anti-CD28 beads only or with the addition of IL-23 and/or IL-1β as indicated. (B) Protein levels for IL-17, IL-22, and IFN-γ in culture supernatant from normal CD4 T memory cells. Data shown from 8 donors are representative of 15 donors from independent experiments. (C and D) Frequency of viable cells was measured in a colorimetric assay based on enzymatic activity. Cell viability after culture without cytokine stimulation (C) was set as the 100% value to calculate cytokine-induced proliferative responses per donor (D). The bar diagram represents mean values for the eight different donors depicted in C (error bars = SD). The dashed line indicates baseline proliferation in cultures without cytokine stimulation set as 100% value. (E) Transcriptional expression of il17, il22, and ifng in T cells from healthy donors was assessed by qRT-PCR. CD161+ cells from 11 different donors were analyzed with corresponding analysis for CD161− cells from 4 of those donors. (F) IL-17, IL-22, and IFN-γ protein levels in culture supernatant from CD patients' T cells. Data are shown for eight different donors. IL-17 levels for CD subject no. 8 exceeded the scale (values for CD161+ cells with values for CD161− cells in brackets: media, 4,298 [497] pg/ml; IL-23, 7,198 [1,248] pg/ml; IL-1β, 7,943 [946] pg/ml; and IL-23 + IL-1β, 10,911 [1,386] pg/ml). Individual symbols represent individual donors to visualize trends per donor (B, E, and F). Horizontal bars represent medians (B, C, E, and F).](https://figures.cochat.ai/paper-figures/4edf96357beb48f7a675613bbbfc1751/circulating-and-gut-resident-human-th17-cells-express-cd161-and-promote-figure-3.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“However, Th17 can be distinguished by the expression of the killer-cell lectin-like receptor CD161 (KLRB1) [155,156], while Th22 expresses the skin-homing receptor CCR10 [154].”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [155]
In the citing paper
“IL-17 production is increased during inflammatory bowel disease (Kleinschek et al., 2009), yet healthy intestine also contains significant populations of IL-17-producing cells.”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Kleinschek et al., 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
the NIDDK IBD Genetics Consortium, Barrett, J. C., the Belgian-French IBD Consortium, the Wellcome Trust Case Control Consortium, Hansoul, S., Nicolae, D. L., Cho, J. H., Duerr, R. H., Rioux, J. D., Brant, S. R., et al. (2008) · Nature Genetics · doi:10.1038/ng.175 · Cited by 2,593
Development, cytokine profile and function of human interleukin 17-producing helper T cells
Wilson, N. J., Boniface, K., Chan, J. R., McKenzie, B. S., Blumenschein, W. M., Mattson, J. D., Basham, B., Smith, K., Chen, T., Morel, F., et al. (2007) · Nature Immunology · doi:10.1038/ni1497 · Cited by 2,035
Self-citationPhenotypic and functional features of human Th17 cells
Annunziato, F., Cosmi, L., Santarlasci, V., Maggi, L., Liotta, F., Mazzinghi, B., Parente, E., Filì, L., Ferri, S., Frosali, F., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070663 · Cited by 1,861
Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells
Acosta-Rodriguez, E. V., Rivino, L., Geginat, J., Jarrossay, D., Gattorno, M., Lanzavecchia, A., Sallusto, F., & Napolitani, G. (2007) · Nature Immunology · doi:10.1038/ni1467 · Cited by 1,828
The Biological Functions of T Helper 17 Cell Effector Cytokines in Inflammation
Ouyang, W., Kolls, J. K., & Zheng, Y. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.004 · Cited by 1,700
α4β7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1
Berlin, C., Berg, E. L., Briskin, M. J., Andrew, D. P., Kilshaw, P. J., Holzmann, B., Weissman, I. L., Hamann, A., & Butcher, E. C. (1993) · Cell · doi:10.1016/0092-8674(93)90305-a · Cited by 1,453
Anatomical basis of tolerance and immunity to intestinal antigens
Mowat, A. M. (2003) · Nature Reviews Immunology · doi:10.1038/nri1057 · Cited by 1,415
Parham, C., Chirica, M., Timans, J., Vaisberg, E., Travis, M., Cheung, J., Pflanz, S., Zhang, R., Singh, K. P., Vega, F., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5699 · Cited by 1,296
Self-citationTesmer, L. A., Lundy, S. K., Sarkar, S., & Fox, D. A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00628.x · Cited by 1,102
Research works printed but not linked: 1
- Warrington, 2001, CD4+,CD28− T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems, Arthritis Rheum., 44, 13, 10.1002/1529-0131(200101)44:1<13::AID-ANR3>3.0.CO;2-6 · doi:10.1002/1529-0131(200101)44:1<13::aid-anr3>3.0.co;2-6
Cited by
Cytokines in inflammatory bowel disease
Neurath, M. F. (2014) · Nature Reviews Immunology · doi:10.1038/nri3661 · Cited by 2,706
Regulation and Functions of the IL-10 Family of Cytokines in Inflammation and Disease
Ouyang, W., Rutz, S., Crellin, N. K., Valdez, P. A., & Hymowitz, S. G. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101312 · Cited by 1,925
Intestinal homeostasis and its breakdown in inflammatory bowel disease
Maloy, K. J., & Powrie, F. (2011) · Nature · doi:10.1038/nature10208 · Cited by 1,870
The IL-17 Family of Cytokines in Health and Disease
McGeachy, M. J., Cua, D. J., & Gaffen, S. L. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.021 · Cited by 1,443
“Similarly, IL-17 production is increased during inflammatory bowel disease (Kleinschek et al., 2009), yet healthy intestine also contains significant populations of IL-17-producing cells.”
BackgroundFunctional Specialization of Interleukin-17 Family Members
Iwakura, Y., Ishigame, H., Saijo, S., & Nakae, S. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.012 · Cited by 1,289
Proinflammatory Cytokines in the Pathogenesis of Inflammatory Bowel Diseases
Strober, W., & Fuss, I. J. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.02.016 · Cited by 1,102
Sonnenberg, G. F., Fouser, L. A., & Artis, D. (2011) · Nature Immunology · doi:10.1038/ni.2025 · Cited by 1,044
Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17–secreting T cells
Dusseaux, M., Martin, E., Serriari, N., Péguillet, I., Premel, V., Louis, D., Milder, M., Le Bourhis, L., Soudais, C., Treiner, E., et al. (2011) · Blood · doi:10.1182/blood-2010-08-303339 · Cited by 1,027
Cytokine Networks in the Pathophysiology of Inflammatory Bowel Disease
Friedrich, M., Pohin, M., & Powrie, F. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.017 · Cited by 750
Circulating Th17, Th22, and Th1 Cells Are Increased in Psoriasis
Kagami, S., Rizzo, H. L., Lee, J. J., Koguchi, Y., & Blauvelt, A. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.399 · Cited by 640
IL-23–responsive innate lymphoid cells are increased in inflammatory bowel disease
Geremia, A., Arancibia-Cárcamo, C. V., Fleming, M. P. P., Rust, N., Singh, B., Mortensen, N. J., Travis, S. P. L., & Powrie, F. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101712 · Cited by 640
JAK–STAT pathway targeting for the treatment of inflammatory bowel disease
Salas, A., Hernandez-Rocha, C., Duijvestein, M., Faubion, W., McGovern, D., Vermeire, S., Vetrano, S., & Vande Casteele, N. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0273-0 · Cited by 635
Self-citationTissue-Resident T Cells and Other Resident Leukocytes
Masopust, D., & Soerens, A. G. (2019) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053214 · Cited by 608
Immunological pathogenesis of inflammatory bowel disease
Lee, S. H., Kwon, J. E., & Cho, M.-L. (2018) · Intestinal Research · doi:10.5217/ir.2018.16.1.26 · Cited by 575
Kim, S., Goel, R., Kumar, A., Qi, Y., Lobaton, G., Hosaka, K., Mohammed, M., Handberg, E. M., Richards, E. M., Pepine, C. J., et al. (2018) · Clinical Science · doi:10.1042/cs20180087 · Cited by 542
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
Cossarizza, A., Chang, H., Radbruch, A., Abrignani, S., Addo, R., Akdis, M., Andrä, I., Andreata, F., Annunziato, F., Arranz, E., et al. (2021) · European Journal of Immunology · doi:10.1002/eji.202170126 · Cited by 531
The emerging role of resident memory T cells in protective immunity and inflammatory disease
Park, C. O., & Kupper, T. S. (2015) · Nature Medicine · doi:10.1038/nm.3883 · Cited by 517
Wang, J., Li, F., Wei, H., Lian, Z.-X., Sun, R., & Tian, Z. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20140625 · Cited by 490
Boniface, K., Bak-Jensen, K. S., Li, Y., Blumenschein, W. M., McGeachy, M. J., McClanahan, T. K., McKenzie, B. S., Kastelein, R. A., Cua, D. J., & de Waal Malefyt, R. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082293 · Cited by 479
Self-citationThe Th17 pathway and inflammatory diseases of the intestines, lungs, and skin
Weaver, C. T., Elson, C. O., Fouser, L. A., & Kolls, J. K. (2013) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130318 · Cited by 462
“Immunopathogenesis of inflammatory bowel disease (IBD).”
BackgroundInfluentialFeagan, B. G., Sandborn, W. J., D'Haens, G., Panés, J., Kaser, A., Ferrante, M., Louis, E., Franchimont, D., Dewit, O., Seidler, U., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30570-6 · Cited by 451
Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment
Nistala, K., Adams, S., Cambrook, H., Ursu, S., Olivito, B., de Jager, W., Evans, J. G., Cimaz, R., Bajaj-Elliott, M., & Wedderburn, L. R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003852107 · Cited by 443
Ramesh, R., Kozhaya, L., McKevitt, K., Djuretic, I. M., Carlson, T. J., Quintero, M. A., McCauley, J. L., Abreu, M. T., Unutmaz, D., & Sundrud, M. S. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20130301 · Cited by 440
Tan, T. G., Sefik, E., Geva-Zatorsky, N., Kua, L., Naskar, D., Teng, F., Pasman, L., Ortiz-Lopez, A., Jupp, R., Wu, H.-J. J., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617460113 · Cited by 427
IL‐22, not simply a Th17 cytokine
Rutz, S., Eidenschenk, C., & Ouyang, W. (2013) · Immunological Reviews · doi:10.1111/imr.12027 · Cited by 435
Gerlach, K., Hwang, Y., Nikolaev, A., Atreya, R., Dornhoff, H., Steiner, S., Lehr, H.-A., Wirtz, S., Vieth, M., Waisman, A., et al. (2014) · Nature Immunology · doi:10.1038/ni.2920 · Cited by 407
Wambre, E., Bajzik, V., DeLong, J. H., O’Brien, K., Nguyen, Q.-A., Speake, C., Gersuk, V. H., DeBerg, H. A., Whalen, E., Ni, C., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aam9171 · Cited by 391
Billerbeck, E., Kang, Y.-H., Walker, L., Lockstone, H., Grafmueller, S., Fleming, V., Flint, J., Willberg, C. B., Bengsch, B., Seigel, B., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914839107 · Cited by 369
CD161 is a marker of all human IL‐17‐producing T‐cell subsets and is induced by RORC
Maggi, L., Santarlasci, V., Capone, M., Peired, A., Frosali, F., Crome, S. Q., Querci, V., Fambrini, M., Liotta, F., Levings, M. K., et al. (2010) · European Journal of Immunology · doi:10.1002/eji.200940257 · Cited by 362
IL-7 Licenses Activation of Human Liver Intrasinusoidal Mucosal-Associated Invariant T Cells
Tang, X.-Z., Jo, J., Tan, A. T., Sandalova, E., Chia, A., Tan, K. C., Lee, K. H., Gehring, A. J., De Libero, G., & Bertoletti, A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203218 · Cited by 356
Differential Roles for Interleukin-23 and Interleukin-17 in Intestinal Immunoregulation
Maxwell, J. R., Zhang, Y., Brown, W. A., Smith, C. L., Byrne, F. R., Fiorino, M., Stevens, E., Bigler, J., Davis, J. A., Rottman, J. B., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.08.019 · Cited by 342
“Th17 cells are increased in Crohn’s disease patients and are a pathogenic cell type in various mouse disease models (Ahern et al., 2008, 2010; Gaffen et al., 2014; Khanna et al., 2014; Kleinschek et al., 2009).”
BackgroundInfluentialHovhannisyan, Z., Treatman, J., Littman, D. R., & Mayer, L. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.12.002 · Cited by 339
Hegazy, A. N., West, N. R., Stubbington, M. J. T., Wendt, E., Suijker, K. I. M., Datsi, A., This, S., Danne, C., Campion, S., Duncan, S. H., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.07.047 · Cited by 338
Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation
Cader, M. Z., & Kaser, A. (2013) · Gut · doi:10.1136/gutjnl-2012-303955 · Cited by 337
The microbiome and regulation of mucosal immunity
McDermott, A. J., & Huffnagle, G. B. (2014) · Immunology · doi:10.1111/imm.12231 · Cited by 334
Th17 cells: new players in asthma pathogenesis: T lymphocytes and asthma phenotypes
Cosmi, L., Liotta, F., Maggi, E., Romagnani, S., & Annunziato, F. (2011) · Allergy · doi:10.1111/j.1398-9995.2011.02576.x · Cited by 326
CD161 Defines a Transcriptional and Functional Phenotype across Distinct Human T Cell Lineages
Fergusson, J. R., Smith, K. E., Fleming, V. M., Rajoriya, N., Newell, E. W., Simmons, R., Marchi, E., Björkander, S., Kang, Y.-H., Swadling, L., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.09.045 · Cited by 311
New targets for mucosal healing and therapy in inflammatory bowel diseases
Neurath, M. F. (2014) · Mucosal Immunology · doi:10.1038/mi.2013.73 · Cited by 309
Cosmi, L., Maggi, L., Santarlasci, V., Capone, M., Cardilicchia, E., Frosali, F., Querci, V., Angeli, R., Matucci, A., Fambrini, M., et al. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.10.012 · Cited by 302
Sarcoidosis is a Th1/Th17 multisystem disorder
Facco, M., Cabrelle, A., Teramo, A., Olivieri, V., Gnoato, M., Teolato, S., Ave, E., Gattazzo, C., Fadini, G. P., Calabrese, F., et al. (2011) · Thorax · doi:10.1136/thx.2010.140319 · Cited by 295
Human T H 17 Cells Are Long-Lived Effector Memory Cells
Kryczek, I., Zhao, E., Liu, Y., Wang, Y., Vatan, L., Szeliga, W., Moyer, J., Klimczak, A., Lange, A., & Zou, W. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002949 · Cited by 278
Muñoz, M., Heimesaat, M. M., Danker, K., Struck, D., Lohmann, U., Plickert, R., Bereswill, S., Fischer, A., Dunay, I. R., Wolk, K., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090900 · Cited by 277
IBD immunopathogenesis: A comprehensive review of inflammatory molecules
Park, J. H., Peyrin-Biroulet, L., Eisenhut, M., & Shin, J. I. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.02.013 · Cited by 276
Crome, S. Q., Wang, A. Y., & Levings, M. K. (2009) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2009.04037.x · Cited by 275
Development and function of TH17 cells in health and disease
Louten, J., Boniface, K., & de Waal Malefyt, R. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.04.003 · Cited by 266
Self-citationDi Meglio, P., Di Cesare, A., Laggner, U., Chu, C.-C., Napolitano, L., Villanova, F., Tosi, I., Capon, F., Trembath, R. C., Peris, K., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017160 · Cited by 262
Cytokines IL-17 and IL-22 in the host response to infection
Valeri, M., & Raffatellu, M. (2016) · Pathogens and Disease · doi:10.1093/femspd/ftw111 · Cited by 202
Heterogeneity of human effector CD4+ T cells
Annunziato, F., & Romagnani, S. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2843 · Cited by 194
CD161 defines the subset of FoxP3+ T cells capable of producing proinflammatory cytokines
Pesenacker, A. M., Bending, D., Ursu, S., Wu, Q., Nistala, K., & Wedderburn, L. R. (2013) · Blood · doi:10.1182/blood-2012-08-443473 · Cited by 175
Aschenbrenner, D., Quaranta, M., Banerjee, S., Ilott, N., Jansen, J., Steere, B., Chen, Y.-H., Ho, S., Cox, K., Arancibia-Cárcamo, C. V., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-321731 · Cited by 123
Bhaumik, S., & Basu, R. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00254 · Cited by 119
Cohen, C. J., Crome, S. Q., MacDonald, K. G., Dai, E. L., Mager, D. L., & Levings, M. K. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101058 · Cited by 112
Local heroes or villains: tissue-resident memory T cells in human health and disease
Sasson, S. C., Gordon, C. L., Christo, S. N., Klenerman, P., & Mackay, L. K. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-019-0359-1 · Cited by 111
Identity crisis of Th17 cells: many forms, many functions, many questions
Sundrud, M. S., & Trivigno, C. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.10.021 · Cited by 77
Th17 cell pathogenicity in autoimmune disease
Park, E., & Ciofani, M. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01535-9 · Cited by 75
Mortensen, R., Nissen, T. N., Blauenfeldt, T., Christensen, J. P., Andersen, P., & Dietrich, J. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500804 · Cited by 55
Jin, C., Jiang, P., Zhang, Z., Han, Y., Wen, X., Zheng, L., Kuang, W., Lian, J., Yu, G., Qian, X., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53104-9 · Cited by 56
Baba, N., Rubio, M., Kenins, L., Regairaz, C., Woisetschlager, M., Carballido, J. M., & Sarfati, M. (2012) · Human Immunology · doi:10.1016/j.humimm.2012.05.002 · Cited by 52
Metadata
- Authors
- Kleinschek, M. A., Boniface, K., Sadekova, S., Grein, J., Murphy, E. E., Turner, S. P., Raskin, L., Desai, B., Faubion, W. A., de Waal Malefyt, R., Pierce, R. H., McClanahan, T., & Kastelein, R. A.
- Affiliations
- Department of Immunology 1 and 2
- Mayo Clinic (US)
- Corresponding author
- Kleinschek, Melanie A.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2009-03-09
- Volume
- 206
- Issue
- 3
- Pages
- 525-534
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2699125
- OpenAlex
- W1975164490
- Cited by
- 460
- References
- 32
- Citations by year
- 2026: 6 · 2025: 8 · 2024: 12 · 2023: 16 · 2022: 15 · 2021: 18 · 2020: 20 · 2019: 22 · 2018: 20 · 2017: 31 · 2016: 35 · 2015: 29 · 2014: 34 · 2013: 36 · 2012: 38
- FWCI
- 22.43
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- CD161, Th17 cells, CD4+ T cells, Crohn's disease, intestinal inflammation, IL-23, IL-17, IL-22, IL23R, gut homing, CCR6, beta7 integrin, T cell activation, colitis
- MeSH terms
- Cell Movement, Crohn Disease, T-Lymphocytes, Helper-Inducer, Humans, Immunologic Memory, Inflammation, Interferon-gamma, Intestines, Lymphocyte Activation, Organ Specificity, Phenotype, Interleukin-17, Interleukin-23, NK Cell Lectin-Like Receptor Subfamily B
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.